FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387241587> ?p ?o ?g. }

• W4387241587 endingPage "8587" @default.
• W4387241587 startingPage "8579" @default.
• W4387241587 abstract "Gelanxinning capsule (GXSC) is a Chinese medicine to cure coronary artery disease (CAD) and a compound of Pueraria lobata, hawthorn extract, and gypenosides. However, whether GXSC could improve coronary microvascular dysfunction (CMD) is unknown. We aimed to demonstrate the therapeutic effect of GXSC on CMD and its underlying mechanisms in CAD patients.This was a single-center, randomized control trial. A total of 78 patients diagnosed by selective coronary angiography (CAG) participated in this study. Patients' demographics, medical history, medications, and results of laboratory testing were collected. The index of microcirculatory resistance (IMR) and coronary flow reserve (CFR) were obtained by CAG and single-photon emission computed tomography (SPECT) separately. Fasting blood samples were obtained on the morning following the admission day. Concentrations of several molecules of inflammation, endothelial function, and coronary microvascular function were measured by ELISA. Patients were followed-up two months after discharge and fasting blood samples were also acquired.All patients were randomly divided into 2 groups: GXSC, 38 (48.7%), and control, 40 (51.3%). The intergroup comparison revealed no significant differences with respect to all baseline variables. As for inflammation biomarkers, proinflammatory NOD-like receptor thermal protein domain associated protein 3 (NLRP3) and interleukin (IL)-1 were significantly decreased in GXSC compared with the control group (0.71±0.08 vs. 1.04±0.07, p<0.01 and 7.16±0.59 vs. 10.93±1.04, p<0.01). Anti-inflammatory adropin was increased in the GXSC group (7.75±0.59 vs. 5.71±0.68, p=0.03). As for indexes of endothelial function, the concentrations of syndecan (SDC) 1, SDC4 and heparan sulphates (HS) were significantly downregulated in 2 months GXSC treatment (3.31±0.28 vs. 4.85±0.43, p<0.01, 3.79±0.56 vs. 5.69±0.68, p=0.03 and 21.31±2.79 vs. 35.18±4.11 p<0.01). In addition, the level of SIRTUIN 1 (SIRT1), which is a vascular protective protein, was upregulated in GXSC group (5.63±0.30 vs. 4.22±0.37, p<0.01). As for molecules of coronary microvascular function, endocan, soluble urokinase plasminogen activator receptor (suPAR), and growth differentiation factor (GDF)-15 were significantly decreased consistently in GXSC compared with the control group (0.09±0.01 vs. 0.19±0.03, p<0.01, 4.44±0.40 vs. 5.73±0.40, p=0.03 and 2.08±0.17 vs. 2.69±0.18, p=0.02).In conclusion, GXSC could improve CMD by inhibiting inflammation and restoring endothelial function. GXSC might be an effective drug in CAD patients without obstructive epicardial coronary arteries but suffering from angina." @default.
• W4387241587 created "2023-10-03" @default.
• W4387241587 creator A5015641842 @default.
• W4387241587 creator A5018574040 @default.
• W4387241587 creator A5025809265 @default.
• W4387241587 creator A5039608131 @default.
• W4387241587 creator A5041130613 @default.
• W4387241587 creator A5046928207 @default.
• W4387241587 creator A5050928135 @default.
• W4387241587 creator A5057209439 @default.
• W4387241587 creator A5066453211 @default.
• W4387241587 creator A5082060071 @default.
• W4387241587 creator A5082959857 @default.
• W4387241587 date "2023-09-01" @default.
• W4387241587 modified "2023-10-17" @default.
• W4387241587 title "Gelanxinning capsule improves coronary microvascular dysfunction by inhibiting inflammation and restoring endothelial function." @default.
• W4387241587 doi "https://doi.org/10.26355/eurrev_202309_33782" @default.
• W4387241587 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37782173" @default.
• W4387241587 hasPublicationYear "2023" @default.
• W4387241587 type Work @default.
• W4387241587 citedByCount "0" @default.
• W4387241587 crossrefType "journal-article" @default.
• W4387241587 hasAuthorship W4387241587A5015641842 @default.
• W4387241587 hasAuthorship W4387241587A5018574040 @default.
• W4387241587 hasAuthorship W4387241587A5025809265 @default.
• W4387241587 hasAuthorship W4387241587A5039608131 @default.
• W4387241587 hasAuthorship W4387241587A5041130613 @default.
• W4387241587 hasAuthorship W4387241587A5046928207 @default.
• W4387241587 hasAuthorship W4387241587A5050928135 @default.
• W4387241587 hasAuthorship W4387241587A5057209439 @default.
• W4387241587 hasAuthorship W4387241587A5066453211 @default.
• W4387241587 hasAuthorship W4387241587A5082060071 @default.
• W4387241587 hasAuthorship W4387241587A5082959857 @default.
• W4387241587 hasConcept C126322002 @default.
• W4387241587 hasConcept C164027704 @default.
• W4387241587 hasConcept C164705383 @default.
• W4387241587 hasConcept C19720800 @default.
• W4387241587 hasConcept C2776914184 @default.
• W4387241587 hasConcept C2778213512 @default.
• W4387241587 hasConcept C2778707443 @default.
• W4387241587 hasConcept C2780972559 @default.
• W4387241587 hasConcept C71924100 @default.
• W4387241587 hasConcept C90924648 @default.
• W4387241587 hasConceptScore W4387241587C126322002 @default.
• W4387241587 hasConceptScore W4387241587C164027704 @default.
• W4387241587 hasConceptScore W4387241587C164705383 @default.
• W4387241587 hasConceptScore W4387241587C19720800 @default.
• W4387241587 hasConceptScore W4387241587C2776914184 @default.
• W4387241587 hasConceptScore W4387241587C2778213512 @default.
• W4387241587 hasConceptScore W4387241587C2778707443 @default.
• W4387241587 hasConceptScore W4387241587C2780972559 @default.
• W4387241587 hasConceptScore W4387241587C71924100 @default.
• W4387241587 hasConceptScore W4387241587C90924648 @default.
• W4387241587 hasIssue "18" @default.
• W4387241587 hasLocation W43872415871 @default.
• W4387241587 hasOpenAccess W4387241587 @default.
• W4387241587 hasPrimaryLocation W43872415871 @default.
• W4387241587 hasRelatedWork W2111764884 @default.
• W4387241587 hasRelatedWork W2167227469 @default.
• W4387241587 hasRelatedWork W2918617645 @default.
• W4387241587 hasRelatedWork W2965806166 @default.
• W4387241587 hasRelatedWork W2981199590 @default.
• W4387241587 hasRelatedWork W3032522106 @default.
• W4387241587 hasRelatedWork W3085613861 @default.
• W4387241587 hasRelatedWork W3103458680 @default.
• W4387241587 hasRelatedWork W3145040827 @default.
• W4387241587 hasRelatedWork W4312740551 @default.
• W4387241587 hasVolume "27" @default.
• W4387241587 isParatext "false" @default.
• W4387241587 isRetracted "false" @default.
• W4387241587 workType "article" @default.